COVID-19 Support Profile: Neopenda

As part of our support package helping businesses react and recover from COVID-19, the KickStage team were privileged to provide manufacturing and supply chain support to Neopenda.

Neopenda , founded in 2015 at Columbia University, is a medical technology startup that aims to develop innovative needs-based medical technologies for emerging markets.

Traditional medical equipment isn’t designed for the majority of the world’s population and frequently fails in resource-constrained health facilities due to unique design constraints like power instability, internet access, space limitations and unavailability of spare parts. Neopenda deploys user-centric design to create affordable solutions that benefit underserved populations and enable high-quality patient care.

98% of the 2.6 million babies that die annually in their first month live in the developing world. 80% of these deaths are preventable. The neoGuard^TM, Neopenda’s first product, is a 4-in-1 vital signs monitoring solution that deploys a wireless, rechargeable and reusable design to continuously monitor pulse rate, respiratory rate, Sp02 and temperature.

Right as the neoGuard^TM was gearing up for large-scale clinical trials, Neopenda’s supply chain was halted by the COVID-19 pandemic. KickStage identified key cost drivers in the design to allow an inexpensive supply chain and tooling reconfiguration. In addition, in response to the global threat of medical supply shortages, the KickStage team utilized innovative rapid prototyping techniques to design and domestically source an extension strap to allow the neoGuard^TM to be deployed for adult patients.

To learn more about Neopenda and how you can support their mission, visit their website here .

KickStage Consulting’s COVID-19 support program is still available to all eligible companies looking to rebound their business and supply chain from the pandemic. For more information,  click here.